Aileron Therapeutics Inc. (ALRN)
2.11
0.18 (9.33%)
At close: Jan 10, 2025, 9:00 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| Net Income | -15.73M | -27.33M | -26.16M | -21.16M | -29.37M | -31.55M | -22.60M | -18.12M | -12.88M | -16.02M | 3.29M |
| Depreciation & Amortization | 119.00K | 169.00K | 121.00K | 163.00K | 155.00K | 218.00K | 129.00K | 232.00K | 325.00K | 585.00K | 774.00K |
| Stock-Based Compensation | 1.19M | 2.08M | 2.26M | 1.89M | 2.12M | 3.28M | 1.75M | 688.00K | 626.00K | 371.00K | 125.00K |
| Other Working Capital | -399.00K | -90.00K | 628.00K | -1.40M | 1.13M | 246.00K | 599.00K | -520.00K | 475.00K | -1.16M | 432.00K |
| Other Non-Cash Items | -4.00K | -208.00K | -213.00K | -95.00K | -226.00K | -253.00K | -11.00K | -18.00K | -21.00K | -1.00M | -18.78M |
| Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -152.00K | 1.51M | n/a | n/a | n/a |
| Change in Working Capital | -5.38M | 420.00K | 242.00K | -1.28M | 850.00K | 376.00K | 358.00K | 695.00K | 238.00K | -1.16M | 432.00K |
| Operating Cash Flow | -19.81M | -24.86M | -23.75M | -20.48M | -26.47M | -27.93M | -20.53M | -15.01M | -11.71M | -17.23M | -14.16M |
| Capital Expenditures | n/a | n/a | -157.00K | -5.00K | -151.00K | -4.42M | -142.00K | n/a | -94.00K | -415.00K | -45.00K |
| Acquisitions | -96.00K | n/a | 66.00K | 208.00K | 2.66K | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | -21.85M | -73.58M | -10.03M | -27.24M | -31.19M | -71.06M | -12.63M | -2.37M | n/a | n/a |
| Sales Maturities Of Investments | 16.25M | 48.31M | 37.75M | 16.24M | 24.57M | 60.30M | 32.29M | 12.63M | 12.38M | n/a | n/a |
| Other Investing Acitivies | 42.00K | 26.46K | -35.76K | 6.42K | -2.66K | 29.11M | -38.77M | -25.00K | 713.00K | -5.89M | -4.12M |
| Investing Cash Flow | 16.20M | 26.46M | -35.92M | 6.41M | -2.81M | 24.69M | -38.91M | -25.00K | 10.63M | -6.30M | -4.17M |
| Debt Repayment | n/a | n/a | n/a | 387.00K | n/a | 2.47M | n/a | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -91.00K | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 15.79M | n/a | 74.00K | n/a | 165.00K | 42.00K | -1.72M | 31.99M | -1.45M | 19.80M | 15.02M |
| Financial Cash Flow | 15.79M | n/a | 55.66M | 15.80M | 23.96M | 2.52M | 50.59M | 31.99M | -1.36M | 19.80M | 15.02M |
| Net Cash Flow | 12.12M | 1.59M | -4.01M | 1.74M | -5.32M | -723.00K | -8.85M | 16.95M | -2.44M | -3.74M | -3.30M |
| Free Cash Flow | -19.81M | -24.86M | -23.91M | -20.48M | -26.63M | -32.35M | -20.67M | -15.01M | -11.80M | -17.65M | -14.20M |